ATE529127T1 - Pharmazeutische zusammensetzung mit arazym zur prävention von leberfunktionsstörung - Google Patents

Pharmazeutische zusammensetzung mit arazym zur prävention von leberfunktionsstörung

Info

Publication number
ATE529127T1
ATE529127T1 AT06835535T AT06835535T ATE529127T1 AT E529127 T1 ATE529127 T1 AT E529127T1 AT 06835535 T AT06835535 T AT 06835535T AT 06835535 T AT06835535 T AT 06835535T AT E529127 T1 ATE529127 T1 AT E529127T1
Authority
AT
Austria
Prior art keywords
arazyme
liver
composition containing
arazym
prevention
Prior art date
Application number
AT06835535T
Other languages
English (en)
Inventor
Ho-Yong Park
Kwang-Hee Son
Dong-Ha Shin
Kyu-Shik Jeong
Original Assignee
Insect Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insect Biotech Co Ltd filed Critical Insect Biotech Co Ltd
Application granted granted Critical
Publication of ATE529127T1 publication Critical patent/ATE529127T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06835535T 2006-12-28 2006-12-28 Pharmazeutische zusammensetzung mit arazym zur prävention von leberfunktionsstörung ATE529127T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2006/005835 WO2008082019A1 (en) 2006-12-28 2006-12-28 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction

Publications (1)

Publication Number Publication Date
ATE529127T1 true ATE529127T1 (de) 2011-11-15

Family

ID=39588676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06835535T ATE529127T1 (de) 2006-12-28 2006-12-28 Pharmazeutische zusammensetzung mit arazym zur prävention von leberfunktionsstörung

Country Status (6)

Country Link
US (2) US20100322917A1 (de)
EP (1) EP2101809B1 (de)
JP (1) JP4954295B2 (de)
CN (1) CN101600452B (de)
AT (1) ATE529127T1 (de)
WO (1) WO2008082019A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101652721B1 (ko) * 2016-07-19 2016-08-31 부산대학교 산학협력단 염증성 장 질환 예방 또는 치료용 조성물
KR101963439B1 (ko) * 2016-10-06 2019-03-29 주식회사 인섹트 바이오텍 아라자임을 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100220091B1 (ko) * 1997-02-27 1999-10-01 박호군 한국산 무당거미의 장으로부터 분리된 신규 미생물 및 그로부터 생성된 단백질분해효소
KR20010077591A (ko) * 2000-02-03 2001-08-20 복성해 아라니콜라 프로테오리티쿠스에서 분리한 신규 금속성단백질 분해효소 및 그의 유전자
US7247467B2 (en) * 2003-09-17 2007-07-24 E. I. Du Pont De Nemours And Company Broad host range pBBR1-based plasmid mutant derivatives having altered plasmid copy number
PT1888074E (pt) * 2005-06-10 2012-03-01 Dong A Pharm Co Ltd Agente para a prevenção e tratamento de doenças do fígado contendo um derivado de pirazolopirimidina
ATE536745T1 (de) * 2006-12-28 2011-12-15 Insect Biotech Co Ltd Zusammensetzung mit arazym zur prävention und behandlung von krebs

Also Published As

Publication number Publication date
JP4954295B2 (ja) 2012-06-13
EP2101809B1 (de) 2011-10-19
CN101600452B (zh) 2013-01-02
JP2010514752A (ja) 2010-05-06
EP2101809A1 (de) 2009-09-23
EP2101809A4 (de) 2011-03-16
WO2008082019A1 (en) 2008-07-10
US20100322917A1 (en) 2010-12-23
US8367060B2 (en) 2013-02-05
US20120003205A1 (en) 2012-01-05
CN101600452A (zh) 2009-12-09

Similar Documents

Publication Publication Date Title
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
WO2009089494A3 (en) Pharmaceutical compositions
NI200900106A (es) Inhibidores de la actividad de la akt.
EA201490254A1 (ru) Комбинированное лечение гепатита с
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
CL2011000488A1 (es) Compuestos derivados de pirazolo-pirimidinas sustituidas; composicion y combinacion farmaceutica que los comprenden; y su uso como inhibidores de pde9 para el tratamiento, alivio y/o prevencion de deterioros cognitivos relacionados con la percepcion, alzheimer,trastornos del sueño, trastorno bipolar, diabetes mellitus.
BR112015020466A8 (pt) inibidores de cdc7, seus usos, e composição farmacêutica
MX2011013201A (es) Composiciones para tratar adiccion a drogas y para mejorar comportamiento relacionado a la adiccion.
AR047993A1 (es) Composicion farmaceutica que comprende pimobendano
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
MX2010002735A (es) Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.
EA201270226A1 (ru) Витамин d3 и его аналогии для лечения алопеции
PH12012500773A1 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
SG11201908234WA (en) Pharmaceutical composition comprising compound capable of penetrating blood-brain barrier as effective ingredient for preventing or treating brain cancer
EA200901237A1 (ru) Применение димирацетама при лечении хронической боли
WO2012106058A3 (en) Animal treatments
BR112012028153A2 (pt) composição farmacêutica e método para o tratamento de hipertensão
WO2016108572A3 (ko) 콜레스테롤 관련 질환의 예방 및 치료용 조성물
WO2009152052A8 (en) Methods of treating alpha adrenergic mediated conditions
WO2009154800A3 (en) Compositions and methods for treating lung disorders
ATE529127T1 (de) Pharmazeutische zusammensetzung mit arazym zur prävention von leberfunktionsstörung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties